Trial Profile
Safety of bevacizumab with adjuvant locoregional radiotherapy in patients with non-metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 15 Dec 2015 New trial record